Last reviewed · How we verify

NCT04966533

Characterize Metzker Pigmentary Disorders

Completed Last updated 19 July 2021
What this trial tests

trial in Pigment Dispersion in 74 participants. Completed in 30 June 2021.

Timeline
1 January 2005
Primary endpoint
30 January 2021
30 June 2021

Quick facts

Lead sponsorUniversity Hospital, Montpellier
StatusCompleted
Study typeOBSERVATIONAL
Enrollment74
Start date1 January 2005
Primary completion30 January 2021
Estimated completion30 June 2021
Sites1 location across France

Conditions studied

Sponsor

University Hospital, Montpellier

Who can join

Under 18, any sex, with Pigment Dispersion or Mosaicism. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Metzker pigmentary disorders are frequent cause of consultation in pediatric dermatology. The investigators can describe 4 patterns. They must be differentiated from mosaicisms because they aren't associated with neurologic disorders and don't require any follow up.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other University Hospital, Montpellier trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04966533.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing